Pictet Asset Management (Switzerland)’s Blueprint Medicines BPMC Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$45.7M	Buy	723,766 +150,122	+26%	+$8.16M	0.05%	305
2023 Q1	$25.8M	Buy	573,644 +411,615	+254%	+$18.5M	0.03%	404
2022 Q4	$7.1M	Sell	162,029 -193,788	-54%	-$9.29M	0.01%	664
2022 Q3	$23.4M	Sell	355,817 -46,925	-12%	-$3.01M	0.03%	395
2022 Q2	$20.3M	Sell	402,742 -264,250	-40%	-$15.5M	0.03%	455
2022 Q1	$42.6M	Sell	666,992 -399,620	-37%	-$28.7M	0.05%	346
2021 Q4	$114M	Buy	1,066,612 +135,596	+15%	+$14.2M	0.11%	216
2021 Q3	$95.7M	Buy	+931,016	New	+$86.7M	0.11%	230

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s BPMC Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Blueprint Medicines (BPMC) stake by 26% in Q2 2023, buying an estimated $8.16M and bringing the position to 723,766 shares worth $45.7M. The position accounts for 0.05% of the portfolio, ranked #305.

Pictet Asset Management (Switzerland) first reported a position in BPMC in Q3 2021 and has held it in 8 quarters since. The position peaked at $114M in Q4 2021. 222 funds tracked by Wall St. Rank hold BPMC as of Q2 2023.

Pictet Asset Management (Switzerland) held 723,766 shares of Blueprint Medicines worth $45.7M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 150,122 Blueprint Medicines shares in Q2 2023, an estimated $8.16M.
Blueprint Medicines made up 0.05% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #305 holding.
Pictet Asset Management (Switzerland) first reported a position in Blueprint Medicines in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Blueprint Medicines position peaked at $114M in Q4 2021.
222 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.